BIO-RAD LABORATORIES

- USD (-)

- 15 min delayed data - NYSE Stocks

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	BIO
ISIN:

BIO-RAD LABORATORIES overview

> Analyses

Londinia AI has published a new analysis for ciuzak2.

0
73113
15112
0

BIO-RAD LABORATORIES - Weekly

Timeframe : Weekly - Simple chart
Status : TARGET REACHED

BIO-RAD LABORATORIES is part of a very strong bearish trend. Traders may consider trading only short positions (for sale) as long as the price remains well below 325.22 USD. The next support located…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis for Vincent Launay.

0
73113
15112
0

BIO-RAD LABORATORIES - Daily

Timeframe : Daily - Simple chart
Status : TARGET REACHED

All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on BIO-RAD LABORATORIES as long as the price remains well above 345.12 USD.…

Thank you Reply Chart

> News ACCESSWIRE published a news.

Bio-Rad Laboratories, Inc. Class A to Host Earnings Call • • ACCESSWIRE • Stocks • More BIO-RAD LABORATORIES news...

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 5:00 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/2872 To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor...

Thank you Chart

> News PR Newswire published a news.

Globavir Announces Licensing Agreement with Bio-Rad for Globavir's Dengue Detection Technology • • PR Newswire • Stocks • More BIO-RAD LABORATORIES news...

Globavir Announces Licensing Agreement with Bio-Rad for Globavir's Dengue Detection Technology PR Newswire LOS ALTOS, Calif., Oct. 17, 2016 LOS ALTOS, Calif. , Oct. 17, 2016 /PRNewswire/ -- Globavir Biosciences, Inc., a biotechnology company that develops therapeutics for infectious diseases and oncology, and diagnostics for infectious diseases, announced a partnership with Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostics products. Under the terms...

Thank you Chart

Load more content